Pre-order Enquiry
Request Free Sample
Global Next Generation Antibody Therapeutics Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14437950 | Publishing Date : 10-Jul-2019 | No. of pages : 90
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Next Generation Antibody Therapeutics Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibody Drug Conjugates (ADCs)
1.4.3 Bispecific Antibodies (BsAbs)
1.4.4 Fc Engineered Antibodies
1.4.5 Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
1.4.6 Biosimilar Antibody (Ab) Products
1.5 Market by Application
1.5.1 Global Next Generation Antibody Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Next Generation Antibody Therapeutics Market Size
2.2 Next Generation Antibody Therapeutics Growth Trends by Regions
2.2.1 Next Generation Antibody Therapeutics Market Size by Regions (2014-2025)
2.2.2 Next Generation Antibody Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Next Generation Antibody Therapeutics Market Size by Manufacturers
3.1.1 Global Next Generation Antibody Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Next Generation Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Next Generation Antibody Therapeutics Key Players Head office and Area Served
3.3 Key Players Next Generation Antibody Therapeutics Product/Solution/Service
3.4 Date of Enter into Next Generation Antibody Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Next Generation Antibody Therapeutics Market Size by Type (2014-2019)
4.2 Global Next Generation Antibody Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Next Generation Antibody Therapeutics Market Size (2014-2019)
5.2 Next Generation Antibody Therapeutics Key Players in United States
5.3 United States Next Generation Antibody Therapeutics Market Size by Type
5.4 United States Next Generation Antibody Therapeutics Market Size by Application
6 Europe
6.1 Europe Next Generation Antibody Therapeutics Market Size (2014-2019)
6.2 Next Generation Antibody Therapeutics Key Players in Europe
6.3 Europe Next Generation Antibody Therapeutics Market Size by Type
6.4 Europe Next Generation Antibody Therapeutics Market Size by Application
7 China
7.1 China Next Generation Antibody Therapeutics Market Size (2014-2019)
7.2 Next Generation Antibody Therapeutics Key Players in China
7.3 China Next Generation Antibody Therapeutics Market Size by Type
7.4 China Next Generation Antibody Therapeutics Market Size by Application
8 Japan
8.1 Japan Next Generation Antibody Therapeutics Market Size (2014-2019)
8.2 Next Generation Antibody Therapeutics Key Players in Japan
8.3 Japan Next Generation Antibody Therapeutics Market Size by Type
8.4 Japan Next Generation Antibody Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Next Generation Antibody Therapeutics Market Size (2014-2019)
9.2 Next Generation Antibody Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Next Generation Antibody Therapeutics Market Size by Type
9.4 Southeast Asia Next Generation Antibody Therapeutics Market Size by Application
10 India
10.1 India Next Generation Antibody Therapeutics Market Size (2014-2019)
10.2 Next Generation Antibody Therapeutics Key Players in India
10.3 India Next Generation Antibody Therapeutics Market Size by Type
10.4 India Next Generation Antibody Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Next Generation Antibody Therapeutics Market Size (2014-2019)
11.2 Next Generation Antibody Therapeutics Key Players in Central & South America
11.3 Central & South America Next Generation Antibody Therapeutics Market Size by Type
11.4 Central & South America Next Generation Antibody Therapeutics Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Next Generation Antibody Therapeutics Introduction
12.1.4 Pfizer Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Next Generation Antibody Therapeutics Introduction
12.2.4 Roche Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Next Generation Antibody Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Next Generation Antibody Therapeutics Introduction
12.4.4 Amgen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Next Generation Antibody Therapeutics Introduction
12.5.4 AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Next Generation Antibody Therapeutics Introduction
12.6.4 Bayer Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Takeda Pharmaceuticals
12.7.1 Takeda Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Next Generation Antibody Therapeutics Introduction
12.7.4 Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.7.5 Takeda Pharmaceuticals Recent Development
12.8 Biogen
12.8.1 Biogen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Next Generation Antibody Therapeutics Introduction
12.8.4 Biogen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.8.5 Biogen Recent Development
12.9 Seattle Genetics
12.9.1 Seattle Genetics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Next Generation Antibody Therapeutics Introduction
12.9.4 Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.9.5 Seattle Genetics Recent Development
12.10 ImmunoGen
12.10.1 ImmunoGen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Next Generation Antibody Therapeutics Introduction
12.10.4 ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)
12.10.5 ImmunoGen Recent Development
12.11 Kyowa Hakko Kirin
12.12 Xencor
12.13 Dyax Corp
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Next Generation Antibody Therapeutics Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable Next Generation Antibody Therapeutics Key Market Segments
Table Key Players Next Generation Antibody Therapeutics Covered
Table Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Next Generation Antibody Therapeutics Market Size Market Share by Type 2014-2025
Figure Antibody Drug Conjugates (ADCs) Figures
Table Key Players of Antibody Drug Conjugates (ADCs)
Figure Bispecific Antibodies (BsAbs) Figures
Table Key Players of Bispecific Antibodies (BsAbs)
Figure Fc Engineered Antibodies Figures
Table Key Players of Fc Engineered Antibodies
Figure Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Figures
Table Key Players of Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
Figure Biosimilar Antibody (Ab) Products Figures
Table Key Players of Biosimilar Antibody (Ab) Products
Table Global Next Generation Antibody Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Next Generation Antibody Therapeutics Report Years Considered
Table Global Next Generation Antibody Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Next Generation Antibody Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Next Generation Antibody Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Next Generation Antibody Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Next Generation Antibody Therapeutics Market Share by Regions 2014-2019
Figure Global Next Generation Antibody Therapeutics Market Share by Regions 2014-2019
Figure Global Next Generation Antibody Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Next Generation Antibody Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Next Generation Antibody Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Next Generation Antibody Therapeutics Market Share by Manufacturers in 2018
Table Global Next Generation Antibody Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Next Generation Antibody Therapeutics Product/Solution/Service
Table Date of Enter into Next Generation Antibody Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Next Generation Antibody Therapeutics Market Size Share by Type (2014-2019)
Figure Global Next Generation Antibody Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Next Generation Antibody Therapeutics Market Size Share by Application (2014-2019)
Figure Global Next Generation Antibody Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Next Generation Antibody Therapeutics Revenue Market Share by Application in 2018
Figure United States Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table United States Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table United States Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure Europe Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table Europe Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table Europe Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure China Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table China Next Generation Antibody Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table China Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure Japan Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table Japan Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table Japan Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table Southeast Asia Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure India Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table India Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table India Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Next Generation Antibody Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Next Generation Antibody Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Next Generation Antibody Therapeutics Market Share (2018-2019)
Table Central & South America Next Generation Antibody Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Next Generation Antibody Therapeutics Market Share by Type (2014-2019)
Table Central & South America Next Generation Antibody Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Next Generation Antibody Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Next Generation Antibody Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Amgen Company Details
Table Amgen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Bayer Company Details
Table Bayer Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Takeda Pharmaceuticals Company Details
Table Takeda Pharmaceuticals Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Pharmaceuticals Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Takeda Pharmaceuticals Recent Development
Table Biogen Company Details
Table Biogen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Biogen Recent Development
Table Seattle Genetics Company Details
Table Seattle Genetics Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure Seattle Genetics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table Seattle Genetics Recent Development
Table ImmunoGen Company Details
Table ImmunoGen Revenue in Next Generation Antibody Therapeutics Business (2014-2019)(Million US$)
Figure ImmunoGen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2014-2019)
Table ImmunoGen Recent Development
Table Kyowa Hakko Kirin Company Details
Table Xencor Company Details
Table Dyax Corp Company Details
Table Global Next Generation Antibody Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Next Generation Antibody Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Next Generation Antibody Therapeutics Market Size Share by Regions in 2025
Figure United States Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Next Generation Antibody Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Next Generation Antibody Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Next Generation Antibody Therapeutics Market Size by Product (2019-2025)
Figure Global Next Generation Antibody Therapeutics Market Size by Product in 2025
Table Global Next Generation Antibody Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Next Generation Antibody Therapeutics Market Size by Application (2019-2025)
Figure Global Next Generation Antibody Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Next Generation Antibody Therapeutics Market Size, Status and Forecast 2019-2025
PfizerRoche
Bristol-Myers Squibb
Amgen
AstraZeneca
Bayer
Takeda Pharmaceuticals
Biogen
Seattle Genetics
ImmunoGen
Kyowa Hakko Kirin
Xencor
Dyax Corp
